Groups Treatment Aspartate Transaminase
(iu/l) I 100 mg/kg BJME 38.00 [+ or -] 5.83 * II 200 mg/kg BJME 35.50 [+ or -] 299 * III 300 mg/kg BJME 41.50 [+ or -] 2.99 ($) * IV 400 mg/kg BJME 40.25 [+ or -] 2.39 ($) * V 2ml/kg Tween 80 28.25 [+ or -] 3.71 VI Water 20.50 [+ or -] 0.65 F-ratio 5.504 Sig 0.003 Parameters Groups Alanine transaminases Alkaline phosphatase (iu/l) (iu/l) I 89.75 [+ or -] 14.10 * 81.68 [+ or -] 21.70 II 51.25 [+ or -] 11.32 79.43 [+ or -] 20.33 III 82.25 [+ or -] 13.55 ($) * 63.05 [+ or -] 14.93 IV 73.75 [+ or -] 17.23 * 45.90 [+ or -] 1622 V 41.50 [+ or -] 2.33 57.25 [+ or -] 5.48 VI 3875 [+ or -] 0.85 64.75 [+ or -] 11.83 3.525 0.712 0.021 0.622 Data expressed in mean [+ or -] SEM; * and $- p<0.05 when compared to the groups V and VI respectively
Table II.- Effect of raw and I3-irradiated pomegranate peels aqueous extract on serum aspartate transaminase
(AST), alanine transaminase (ALT), I3-glutamyl transferase (I3GT) and alkaline phosphatase (ALP) activities and testosterone (T), luteinizing hormone (LH) and follicle stimulating hormone (FSH) levels in rats treated with hepatotoxic dose of lead acetate.
The blood chemistry results were BUN, 90 mg/L; creatinine, 7.9 mg/L; aspartate transaminase
, 22 U/L; alanine transaminase, 15 U/L; total bilirubin, 3.1 mg/L; lactate dehydrogenase, 213 U/L; creatine phosphokinase, 49 U/L; C-reactive protein, 59.4 mg/L; and procalcitonin, 23.62 ng/ml.
Results: Overall alanine transaminase and aspartate transaminase
(ALT and AST) were raised, i.e.
Statistically significant reductions in live enzymes alanine transaminase and aspartate transaminase
were demonstrated in both Aramchol arms vs.
The findings, by SRL Diagnostics, showed that young adults had more abnormalities in liver enzymes, known as aminotransferases, which include alanine transaminase (ALT or SGPT) and aspartate transaminase
(AST or SGOT).
Association between serum aspartate transaminase
and homocysteine levels in hemodialysis patients.
In the patient, leucocyte was 6.52 x [10.sup.9]/L, hemoglobin was 147 g/L, hematocrit was 46.6%, thrombocyte was 58 x [10.sup.9]/L, aspartate transaminase
was 79.8 U/L, alanine transaminase was 116.9 U/L, gamma-glutamyl transferase was 156 U/L, alkaline phosphatase was 1114 U/L, total bilirubin was 0.98 mg/dL, direct bilirubin was 0.6 mg/dL and other biochemistry values were all normal.
Laboratory investigations demonstrated a white blood cell count of 7500 counts/[micro]L, a platelet count of 283000 counts/[micro]L, 15.2 g/dL hemoglobulin, 92 g/L glucose, 0.9 g/L creatinine, 139.6 mEq/L sodium, 3.32 mEq/L potassium, 19 IU/L aspartate transaminase
, 25 IU/L alanine transaminase, and 12.8 mg/L VPA levels.
Serum levels of gamma-glutamyl transferase, aspartate transaminase
, alanine transaminase, alpha-fetoprotein, carbohydrate antigen 19-9 and carcinoembryonic antigen were normal.
 Nonstandard abbreviations: SCD, sickle cell disease; RBC, red blood cell; DTI, direct thrombin inhibitor; HIT, heparin-induced thrombocytopenia; PTT, partial thromboplastin time; MSG, monosodium glutamate; AST, aspartate transaminase
; SAM, 5-adenosyl methionine; t-PA, tissue plasminogen activator; NAC, N-acetyl-L-cysteine; ALT, alanine transaminase.
ALT = alanine transaminase; AST = aspartate transaminase
; BUN = blood urea nitrogen; eGFR = estimated glomerular filtration rate; g = grams; L = liter; and mg = milligrams.